跳至主要内容
临床试验/NCT05292885
NCT05292885Unknown不适用

Mp-MRI in the Diagnosis of Liver Fibrosis After Liver Transplantation

The Affiliated Hospital of Qingdao University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年3月18日最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Mp-MRI in the Diagnosis of Liver Fibrosis After Liver Transplantation

研究概览

简要总结

It is an open label observation clinical trial, all participants are liver transplant patients. The investigators deem to make a better criteria for assessing liver fibrosis after liver transplantation. The point of the clinical trial is to evaluate the efficacy of multiparameter MRI in the diagnosis of liver fibrosis after liver transplantation.

详细描述

We collected patients aged 18 to 85 who had undergone liver transplantation. At the same time, all patients underwent liver biopsy or ultrasonic transient elastography after MRI. People who were allergic to gadolinium contrast agent, serious cardiopulmonary disease and contraindications to MRI were excluded.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects aged 18 -85 years
  • Patients after liver transplantation
  • Patients who are going to undergo liver biopsy or ultrasonic transient elastography
  • Patients voluntarily joined the study and signed informed consent

排除标准

  • Patients with tumor
  • Patients who are allergic to gadolinium contrast agent
  • Patients with contraindications to magnetic resonance imaging
  • Patients with severe heart and lung diseases
  • Patients who are not suitable for this study according to the researcher's judgment.

结局指标

主要结局

Mp-MRI in the Diagnosis of Liver Fibrosis After Liver Transplantation

时间窗: 03.18.2022 to12.01.2022

Mp-MRI as a PET-CT biomarker to Liver Fibrosis after Liver Transplantation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验